• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 5. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Organonitrogen compounds
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds

Recent Advances in the Application of N,N-bis(cyclopropylmethyl)sulfamoyl chloride (CAS: 1339325-76-6) in Chemical Biology and Pharmaceutical Research

N,N-bis(cyclopropylmethyl)sulfamoyl chloride (CAS: 1339325-76-6) has recently emerged as a versatile reagent in chemical biology and pharmaceutical research. This sulfamoyl chloride derivative has garnered significant attention due to its unique reactivity profile and potential applications in drug discovery and development. Recent studies have explored its utility as a key intermediate in the synthesis of sulfonamide-based compounds, which are widely recognized for their pharmacological properties.

One of the most notable applications of N,N-bis(cyclopropylmethyl)sulfamoyl chloride is in the development of novel enzyme inhibitors. Researchers have successfully employed this compound in the synthesis of sulfonamide-containing inhibitors targeting various enzymes, including carbonic anhydrases and proteases. The cyclopropylmethyl groups confer enhanced lipophilicity and metabolic stability to the resulting compounds, making them promising candidates for further optimization.

In a recent study published in the Journal of Medicinal Chemistry, researchers utilized N,N-bis(cyclopropylmethyl)sulfamoyl chloride to develop a series of potent and selective inhibitors for a specific isoform of carbonic anhydrase implicated in certain cancers. The study demonstrated that the introduction of the cyclopropylmethyl groups significantly improved the pharmacokinetic properties of the inhibitors while maintaining their target affinity.

Another area of active research involves the use of N,N-bis(cyclopropylmethyl)sulfamoyl chloride in the synthesis of sulfonamide-based prodrugs. The compound's ability to react with various nucleophiles, including amines and alcohols, makes it particularly useful for constructing prodrug linkages that can be cleaved under specific physiological conditions. This approach has been applied to improve the bioavailability of poorly soluble drugs.

Recent synthetic methodology developments have also expanded the utility of N,N-bis(cyclopropylmethyl)sulfamoyl chloride. A 2023 publication in Organic Letters described a novel one-pot procedure for the preparation of unsymmetrical sulfamides using this reagent, offering improved yields and reduced purification steps compared to traditional methods. This advancement has important implications for the efficient synthesis of sulfamide-containing drug candidates.

From a safety and handling perspective, recent studies have provided more detailed information about the stability and storage conditions of N,N-bis(cyclopropylmethyl)sulfamoyl chloride. While the compound is generally stable under inert atmosphere at low temperatures, it has been shown to be moisture-sensitive, requiring careful handling in anhydrous conditions. These findings have important practical implications for researchers working with this reagent.

Looking forward, the unique properties of N,N-bis(cyclopropylmethyl)sulfamoyl chloride suggest continued relevance in pharmaceutical research. Its combination of reactivity and the steric/electronic effects imparted by the cyclopropylmethyl groups make it particularly valuable for the development of next-generation sulfonamide-based therapeutics. Ongoing research is exploring its potential in targeted protein degradation strategies and covalent inhibitor design, areas that are currently at the forefront of drug discovery.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)